Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients. [electronic resource]
Producer: 19980708Description: 1149-51 p. digitalISSN:- 0041-1345
- Adult
- Aged
- Azathioprine -- therapeutic use
- Cyclosporine -- administration & dosage
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Graft Rejection -- epidemiology
- Heart Transplantation -- immunology
- Heart-Lung Transplantation -- immunology
- Humans
- Hypertension -- epidemiology
- Immunosuppressive Agents -- administration & dosage
- Male
- Methylprednisolone -- therapeutic use
- Middle Aged
- Postoperative Complications -- epidemiology
- Renal Dialysis
- Retrospective Studies
- Risk Assessment
- Survival Analysis
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.